Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.
By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:
- Type of Product
- Organ(s) based
- Disease(s) based
- Type of Application Area
- Drug Discovery and Toxicity Testing
- Cancer Research
- Tissue Engineering and Regenerative Medicine
- Stem Cell Research
- Purpose
- Research Use
- Therapy Development
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:
- BEOnChip
- Dynamic42
- Emulate
- MIMETAS
- SynVivo
- TissUse
- uFluidix
Table of Contents
- Preface
- Executive Summary
- Introduction
- Organ-on-Chip: Market Landscape
- Organ-on-Chip Developers: Company Profiles
- Patent Analysis
- Brand Positioning Matrix
- Academic Grants Analysis
- Partnerships and Collaborations
- Funding and Investment Analysis
- Case Study: Scaffold-Free 3D Cell Culture Systems
- Organ-on-Chip: Market Forecast and Opportunity Analysis
- Conclusion
- Executive Insights
- APPENDIX 1: TABULATED DATA
- APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html
You may also be interested in the following titles:
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
